Similarly, in T-47D breast cancer cells made resistant to aromatase inhibitors, which express high levels of aromatase and grow in response to testosterone, telapristone caused growth arrest in association with downregulation of PR-B mRNA and protein levels (Gupta et al. 2013a). The gene discussed is CYP19A1; the disease is breast carcinoma.